Medtronic (NYSE: MDT) today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.

The companies agreed to enhance access to technology from DASI, a leader in AI-driven predictive modeling and digital twin ...

Please provide your email address to receive an email when new articles are posted on . TAVR did not improve a composite of clinical endpoints in patients with moderate aortic stenosis and HFrEF.

SAN FRANCISCO -- Better indicators of high-grade atrioventricular (AV) conduction system abnormalities following transcatheter aortic valve replacement (TAVR) could be gleaned from an intraprocedural ...

Edwards Lifesciences Corporation (NYSE:EW) ranks among the best medical device stocks to invest in. Piper Sandler maintained ...

Saint Alphonsus in Boise earned a three-star TAVR ranking from STS and ACC, placing it among the nation’s top heart programs ...

Early improvement of left ventricular ejection fraction (LVEF) after transcatheter aortic valve replacement (TAVR) is associated with improved all-cause and cardiac death at 5 years in patients with ...

Emboline, Inc., a leading innovator in full-body embolic protection devices for transcatheter procedures, today announced completion of patient enrollment in its Protect the Head to Head (ProtectH2H) ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio NEW ORLEANS — At 3 years, patients with ...

NEW ORLEANS -- Accruing clinical data continue to suggest that the choice between transcatheter aortic valve replacement (TAVR) and surgery is not an easy one for patients at low surgical risk who are ...

Edwards Lifesciences Corp. EW is scheduled to report third-quarter 2025 results on Oct. 30, after market close. In the last ...

Southcoast Health opens new heart and vascular practice in Taunton, expanding access to advanced cardiology care.